placeholder image
member of DURATION-1 Study Group All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. 
    Lancet (London, England). 2008
    • Contact
    full name
  • member of DURATION-1 Study Group
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration